Anti-TNFRSF10B/TRAILR2/CD262 Antibody (Benufutamab)
Catalog No.
F1076
Anti-TNFRSF10B/TRAILR2/CD262 Antibody (Benufutamab)
Featured Products
Benufutamab (GEN1029) is a death receptor 5 (DR5) specific agonistic antibody. Benufutamab is a mixture of 2 non-competitive DR5-specific IgG1 antibodies, each with an E430G mutation in the Fc domain. Benufutamab has anti-tumor effects.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
2109730-69-8
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
HX-DR5-05, GEN1029
100 mM Pro 20 mM Arg pH 5.0. No preservative!
O14763
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
TNFRSF10B / TRAILR2 / CD262
Please avoid freeze-thaw cycles.